Cubic phase gel as a drug delivery system for topical application of 5-ALA, its ester derivatives and m-THPC in photodynamic therapy (PDT)

Journal of Photochemistry and Photobiology B: Biology

Volumn 70, Issue 1, 2003, Pages 1-6

  Turchiello, R F ^a   Vena, F C B ^a   Maillard, Ph ^b   Souza, C S ^a   Bentley, M V B L ^a   Tedesco, A C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUT CURIE   (France)

Author keywords

5 AlA; 5 AlA esters; Fluorescence; m THPC; Monoolein; PDT

Indexed keywords

ALKANE DERIVATIVE; AMINOLEVULINIC ACID; DECANE; ESTER DERIVATIVE; FLUORESCENT DYE; GLYCEROL OLEATE; HEXANE; OCTANE; PHOTOSENSITIZING AGENT; PRODRUG; TETRAKIS(3 HYDROXYPHENYL)CHLORIN; WATER;

ACTINIC KERATOSIS; ARTICLE; CHEMICAL REACTION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG STABILITY; FLUORESCENCE ANALYSIS; GEL; PHOTODYNAMIC THERAPY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SKIN DISEASE; SPECTROSCOPY; TOPICAL TREATMENT;

EID: 0037767363     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1011-1344(03)00022-8     Document Type: Article

References (22)

1. S. Engström, Cubic phases as drug delivery systems, Polym. Prep. (Am. Chem. Soc. Div. Polym. Chem.) 31 (2) (1990) 157-158.
2. D.M. Wyatt, D. Dorschel, A cubic-phase delivery system composed of glyceryl monooleate and water for sustained release of water-soluble drugs, Pharm. Technol. 16 (10) (1992) 116-130.
3. S. Engstrom, T.P. Norden, H. Nyquist, Cubic phases for studies of drug partition into lipid bilayers, Eur. J. Pharm. Sci. 8 (1999) 243-254.
4. S.T. Hyde, S. Andersson, B. Ericsson, K. Larsson, A cubic structure consisting of a lipid bilayer forming an infinite periodic minimum surface of the gyroid type in the glyceryl monooleate-water system, Zeitschrift Kristallogr. 168 (1984) 213-219.
5. T. Norling, P. Landing, S. Engström, K. Larsson, N. Krog, S.S. Nissen, Formulation of a drug delivery system based on a mixture of monoglycerides and triglycerides for use in the treatment of periodontal disease, J. Clin. Periodontol. 19 (1992) 687-692.
6. P.B. Geraghty, D. Attwood, J.H. Collet, Y. Dandiker, The in vitro release of some antimuscarinic drugs from monoolein/water lyotropic liquid crystalline gels, Pharm. Res. 13 (8) (1996) 1265-1271.
7. R.A. His, D.I. Rosenthal, E. Glatstein, Photodynamic therapy in the treatment of cancer, Drugs 57 (1999) 725-734.
8. M. Ochsner, Photophysical and photobiological processes in the photodynamic therapy of tumors, J. Photochem. Photobiol. B: Biol. 39 (1997) 1-18.
9. J.C. Kennedy, R.H. Pottier, D.C. Pross, Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience, J. Photochem. Photobiol. B: Biol. 6 (1990) 143-148.
10. Q. Peng, T. Warloe, K. Berg, J. Moan, M. Kongshaug, K.E. Giercksky, J.M. Nesland, 5-Aminolevulinic acid-based photodynamic therapy: clinical research and future challenges, Cancer 79 (12) (1997) 2282-2308.
11. G. Fabbrocini, M.P. Di Constanzo, A.M. Riccardo, M. Quarto, A. Colasanti, G. Roberti, G. Monfrecola, Photodynamic therapy with topical 5-aminolevulinic acid for the treatment of plantar warts, J. Photochem. Photobiol. B: Biol. 61 (2001) 30-34.
12. A. Leunig, M. Mehlmann, C. Betz, H. Stepp, S. Arbogast, G. Grevers, R. Baumgartner, Fluorescence staining of oral cancer using a topical application of 5-aminolevulinic acid: fluorescence microscopic studies, J. Photochem. Photobiol. B: Biol. 60 (2001) 44-49.
13. P. Juzenas, V. Iani, S. Bagdonas, R. Rotomskis, J. Moan, Fluorescence spectroscopy of normal mouse skin exposed to 5-aminolevulinic acid and red light, J. Photochem. Photobiol. B: Biol. 61 (2001) 78-86.
14. Q. Peng, A.M. Soler, T. Warloe, J.M. Nesland, K. Giercksky, Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulinate, J. Photochem. Photobiol. B: Biol. 62 (2001) 140-145.
15. I. Cosserat-Gerardin, L. Bezdetnaya, D. Notter, C. Vigneron, F. Guillemin, Biosynthesis and photodynamic efficacy of protoporphyrin IX (PpIX) generated by 5-aminolevulinic acid (ALA) or its hexylester (hALA) in rat bladder carcinoma cells, J. Photochem. Photobiol. B: Biol. 59 (2000) 72-79.
16. P. Juzenas, S. Sharfaei, J. Moan, R. Bissonnette, Protoporphyrin IX fluorescence kinetics in UV-induced tumours and normal skin of hairless mice after topical application of 5-aminolevulinic acid methyl ester, J. Photochem. Photobiol. B: Biol. 67 (2002) 11-17.
17. G. Gupta, C.A. Morton, C. Whitehurst, J.V. Moore, R.M. Mackie, Photodynamic therapy with meso-tetra(hydroxyphenyl)chlorine in the topical treatment of Bowen's disease and basal cell carcinoma, Br. J. Dermatol. 141 (1999) 385-386.
18. J. Kloek, G.M.J. Beijersbergen van Henegouwen, Prodrugs of 5-aminolevulinic acid for photodynamic therapy, Photochem. Photobiol. 64 (1996) 994-1000.
19. H. Oishi, H. Nomiyama, K. Nomiyama, K. Tomokuni, Fluorometric HPLC determination of 5-aminolevulinic acid (ALA) in the plasma and urine of lead workers: biological indicators of lead exposure, J. Anal. Toxicol. 20 (1996) 106-110.
20. M. Kajiwara, H. Hara, K. Takatori, K. Matsumoto, Revised structure of 5-aminolevulinic acid derivative, Clin. Chem. 39 (1993) 1867-1871.
21. P.G. Calzavara-Pinton, Repetitive photodynamic therapy with topical 5-aminolevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours, J. Photochem. Photobiol. B: Biol. 29 (1995) 53-57.
22. T. Ogiso, M. Iwaki, T. Paku, Effect of various enhancers on transdermal penetration of indomethacin and urea, and relationship between penetration parameters and enhancement factors, J. Pharm. Sci. 84 (4) (1995) 482-488.